INTRODUCTION AND HYPOTHESIS: This paper aims to determine if there are differences between female overactive bladder (OAB) patients with and without urodynamic detrusor overactivity (DO). METHODS: A retrospective chart review was performed on 146 women with OAB. All patients completed an American Urological Association symptom score, 48-h bladder diary (documenting voided volumes, incontinent episodes, and degree of urgency to void), and urodynamic testing (UDS). Patients with urodynamic DO were then compared to patients without DO. RESULTS: There were no differences in symptom scores. Patients with DO (54.1%) were older (61.8 vs. 50.8 years) and had smaller maximum voided volumes per void (377 mL vs. 476 mL), average 24-h urine output (1,975 mL vs. 2,320 mL), and significantly more incontinent episodes. On UDS, patients with DO were more likely to have abnormal sensation, with strong desire and urgency occurring at significantly lower bladder volumes. CONCLUSION: Despite similar symptomatology, there are objective differences between OAB patients with and without DO.
INTRODUCTION AND HYPOTHESIS: This paper aims to determine if there are differences between female overactive bladder (OAB) patients with and without urodynamic detrusor overactivity (DO). METHODS: A retrospective chart review was performed on 146 women with OAB. All patients completed an American Urological Association symptom score, 48-h bladder diary (documenting voided volumes, incontinent episodes, and degree of urgency to void), and urodynamic testing (UDS). Patients with urodynamic DO were then compared to patients without DO. RESULTS: There were no differences in symptom scores. Patients with DO (54.1%) were older (61.8 vs. 50.8 years) and had smaller maximum voided volumes per void (377 mL vs. 476 mL), average 24-h urine output (1,975 mL vs. 2,320 mL), and significantly more incontinent episodes. On UDS, patients with DO were more likely to have abnormal sensation, with strong desire and urgency occurring at significantly lower bladder volumes. CONCLUSION: Despite similar symptomatology, there are objective differences between OABpatients with and without DO.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: Annabel Nixon; Shoshana Colman; Luann Sabounjian; Bobby Sandage; Ute E Schwiderski; David R Staskin; Norman Zinner Journal: J Urol Date: 2005-08 Impact factor: 7.450
Authors: Stasa D Tadic; Derek Griffiths; Werner Schaefer; Andrew Murrin; Becky Clarkson; Neil M Resnick Journal: Neurourol Urodyn Date: 2012-03-30 Impact factor: 2.696
Authors: Camille P Vaughan; Alayne D Markland; Phillip P Smith; Kathryn L Burgio; George A Kuchel Journal: J Am Geriatr Soc Date: 2017-12-04 Impact factor: 5.562
Authors: Hediye Dağdeviren; Hüseyin Cengiz; Çağlar Helvacıoğlu; Ulkar Heydarova; Cihan Kaya; Murat Ekin Journal: Turk J Obstet Gynecol Date: 2017-12-30